Trending News Today: FDA Panel Recommends Co-prescribing Naloxone with Painkillers

An advisory panel to the FDA recommended prescribing the opioid overdose reversal drug, naloxone, along with opioids, Reuters reported. According to the article, the panel voted 12-11 in favor of labeling changes for opioids that recommend co-prescribing the overdose antidote. Panel members suggested that the prescription of naloxone could facilitate a healthy dialogue between patients and their health care provider, but others argued that co-prescribing could drastically increase health care costs, the article noted.
A federal judge is considering using a court-appointed monitor to ensure that CVS Health does not fully integrate with Aetna while he examines the companies’ settlement with the government, according to Reuters. Judge Richard Leon of the US District Court for the District of Columbia has written that he was “less convinced” than the government that asset sales made by Aetna would resolve antitrust concerns, the article said. The hearing was held as part of his review of the settlement. 
A recent study found that nearly 1 in 10 patients treated with chemotherapy or newer targeted drugs may be hospitalized for serious kidney injury, according to Reuters. The study involved approximately 163,000 patients who started chemotherapy or targeted therapies for a new cancer diagnosis in Ontario, Canada from 2007 to 2014. Overall, 10,880 were hospitalized for serious kidney damage or for dialysis, which translates to a cumulative acute kidney injury rate of 9.3%, the article reported.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.